Tumor M2 Pyruvate Kinase: A Tumor Marker and its Clinical Application in Gastrointestinal Malignancy
colorectal and cholangiocellular cancer. However, no known GI tumor marker can be used as a standard laboratory screening parameter due to low sensitivity and specificity (exception: AFP in ...
Subsequent investigations identified the presence of metastasized cholangiocellular carcinoma. Despite swift commencement of chemotherapy, the patient died of his disease. Sister Mary Joseph ...
Tumor M2 Pyruvate Kinase: A Tumor Marker and its Clinical Application in Gastrointestinal Malignancy
As compared with the established tumor markers, Tumor M2-PK in EDTA-plasma proves to have at least equal sensitivity in pancreatic, gastric, esophageal, colorectal and cholangiocellular cancer.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback